Bloomberg.com: Europe

Bloomberg.com: Europe: "Jan. 25 (Bloomberg) -- Bayer AG's Trasylol, used in more than 60 countries to control bleeding after surgery, doubles a patient's likelihood of developing kidney failure and increases the risk of heart attacks and strokes, researchers said."